Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

There are a couple of ways to look at it (at least

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153908
(Total Views: 735)
Posted On: 12/18/2020 8:25:15 PM
Posted By: RTB
Re: seeking37 #68831
There are a couple of ways to look at it (at least):
1. The negative view is that we are issuing stock at $3.40 while it is trading at $4.99 Call it dilution (the horror)! You could also call prior communication from management misleading (e.g. we are raising money at $10.....followed by repaying the loan (which already included a significant OID) with shares at $3.40). I think that is fair (that prior communication was misleading). But, that is typical around here. Don't be surprised.
2. On the other hand.....you can be damn happy that we aren't going to run out of cash, because NP and MM have found a really clever way of getting "out of" the original note terms. As long as they were stuck with that note at a $10 conversion price, it was a bit of an albatross. When they added a second note and also agreed to immediately repay the second note at $7.5 million per month, we were all confused. Now we aren't confused. They had a methodology to pay the $7.5 million with stock at a value somewhat near market.

So, I think view #2 is the correct way to look at it. Careful readers of my work (there are few) will know that my mantra is "cash is king." I'm glad that they are finding a way to navigate the Fife waters.

p.s. As I read the S-3 details, I think they already did another tranche of this $7.5 million around November 10 with shares priced at 2.60. For some reason, they didn't have to register these shares (yet), so it wasn't disclosed on an s-3. I am basing this part of my comment on footnote 3, section ii, on page 6. I'm pretty confident in my thinking here, but not 100%.

When the book is written, this chapter will be called: When does $10 equal $2.6 or $3.4?


(6)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us